Key Financial Data Of Reporting Company

Fuso Pharmaceutical Industries,Ltd. - Filing #7725247

Concept As at
2018-03-31
2017-04-01 to
2018-03-31
2016-04-01 to
2017-03-31
As at
2017-03-31
As at
2016-03-31
2015-04-01 to
2016-03-31
2014-04-01 to
2015-03-31
As at
2015-03-31
2013-04-01 to
2014-03-31
As at
2014-03-31
Key financial data of reporting company
Business results of reporting company
Net sales
45,900,000,000 JPY
46,782,000,000 JPY
45,752,000,000 JPY
47,042,000,000 JPY
49,098,000,000 JPY
Ordinary profit (loss)
832,000,000 JPY
642,000,000 JPY
172,000,000 JPY
678,000,000 JPY
2,741,000,000 JPY
Profit (loss)
970,000,000 JPY
861,000,000 JPY
10,000,000 JPY
340,000,000 JPY
1,979,000,000 JPY
Equity in earnings (losses) of affiliates if equity method is applied
JPY
JPY
JPY
JPY
JPY
Share capital
10,758,000,000 JPY
10,758,000,000 JPY
10,758,000,000 JPY
10,758,000,000 JPY
10,758,000,000 JPY
Total number of issued shares
9,451,169 xbrli:shares
9,451,169 xbrli:shares
94,511,690 xbrli:shares
94,511,690 xbrli:shares
94,511,690 xbrli:shares
Net assets
32,579,000,000 JPY
32,545,000,000 JPY
32,616,000,000 JPY
33,538,000,000 JPY
34,892,000,000 JPY
Total assets
70,188,000,000 JPY
68,788,000,000 JPY
69,056,000,000 JPY
68,627,000,000 JPY
68,644,000,000 JPY
Net assets per share
3,711.54
3,642.78
3,606.75
3,707.67
3,856.08
Dividend paid per share
80.00
44.00
8.00
8.00
8.00
Interim dividend paid per share
40.00
4.00
4.00
4.00
4.00
Basic earnings (loss) per share
109.61
95.86
1.12
37.67
218.67
Diluted earnings per share
Equity-to-asset ratio
0.464 xbrli:pure
0.473 xbrli:pure
0.472 xbrli:pure
0.489 xbrli:pure
0.508 xbrli:pure
Rate of return on equity
0.030 xbrli:pure
0.026 xbrli:pure
0.000 xbrli:pure
0.010 xbrli:pure
0.058 xbrli:pure
Price-earnings ratio
25.8 xbrli:pure
29.3 xbrli:pure
2,327.1 xbrli:pure
82.6 xbrli:pure
16.6 xbrli:pure
Payout ratio
0.730 xbrli:pure
0.835 xbrli:pure
71.604 xbrli:pure
2.124 xbrli:pure
0.366 xbrli:pure
Net cash provided by (used in) operating activities
1,420,000,000 JPY
1,876,000,000 JPY
2,117,000,000 JPY
1,943,000,000 JPY
2,889,000,000 JPY
Net cash provided by (used in) investing activities
-984,000,000 JPY
-786,000,000 JPY
-5,336,000,000 JPY
-2,890,000,000 JPY
-1,779,000,000 JPY
Net cash provided by (used in) financing activities
69,000,000 JPY
-1,145,000,000 JPY
2,326,000,000 JPY
-955,000,000 JPY
-2,425,000,000 JPY
Cash and cash equivalents
5,457,000,000 JPY
4,951,000,000 JPY
5,006,000,000 JPY
5,898,000,000 JPY
7,801,000,000 JPY
Number of employees
1,366 xbrli:pure
1,374 xbrli:pure
1,362 xbrli:pure
1,385 xbrli:pure
1,366 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.